These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24135150)

  • 21. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AN INTEGRATED PERSPECTIVE ON THE ASSESSMENT OF TECHNOLOGIES: INTEGRATE-HTA.
    Wahlster P; Brereton L; Burns J; Hofmann B; Mozygemba K; Oortwijn W; Pfadenhauer L; Polus S; Rehfuess E; Schilling I; van der Wilt GJ; Gerhardus A
    Int J Technol Assess Health Care; 2017 Jan; 33(5):544-551. PubMed ID: 28756780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surrogate outcomes in health technology assessment: an international comparison.
    Velasco Garrido M; Mangiapane S
    Int J Technol Assess Health Care; 2009 Jul; 25(3):315-22. PubMed ID: 19619350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model.
    Burch J; Hinde S; Palmer S; Beyer F; Minton J; Marson A; Wieshmann U; Woolacott N; Soares M
    Health Technol Assess; 2012; 16(34):1-157, iii-iv. PubMed ID: 22985954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluations conducted by Canadian health technology assessment agencies: where do we stand?
    Tarride JE; McCarron CE; Lim M; Bowen JM; Blackhouse G; Hopkins R; O'Reilly D; Xie F; Goeree R
    Int J Technol Assess Health Care; 2008; 24(4):437-44. PubMed ID: 18828938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art.
    Oliveira MD; Mataloto I; Kanavos P
    Eur J Health Econ; 2019 Aug; 20(6):891-918. PubMed ID: 31006056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using health state utility values in models exploring the cost-effectiveness of health technologies.
    Ara R; Wailoo A
    Value Health; 2012; 15(6):971-4. PubMed ID: 22999149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.
    Makady A; Ham RT; de Boer A; Hillege H; Klungel O; Goettsch W;
    Value Health; 2017 Apr; 20(4):520-532. PubMed ID: 28407993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
    Siebert U; Rochau U; Claxton K
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using decision-analytic modelling to transfer international evidence from health technology assessment to the context of the German health care system.
    Siebert U
    GMS Health Technol Assess; 2005 Nov; 1():Doc03. PubMed ID: 21289924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health economic evaluations using decision analytic modeling. Principles and practices--utilization of a checklist to their development and appraisal.
    Soto J
    Int J Technol Assess Health Care; 2002; 18(1):94-111. PubMed ID: 11987445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Systematic Review of Research Guidelines in Decision-Analytic Modeling.
    Ramos MC; Barton P; Jowett S; Sutton AJ
    Value Health; 2015 Jun; 18(4):512-29. PubMed ID: 26091606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effectiveness of interventions to meet family needs of critically ill patients in an adult intensive care unit: a systematic review update.
    Kynoch K; Chang A; Coyer F; McArdle A
    JBI Database System Rev Implement Rep; 2016 Mar; 14(3):181-234. PubMed ID: 27532144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
    Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
    Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decision analytic modeling in spinal surgery: a methodologic overview with review of current published literature.
    McAnany SJ; Anwar MA; Qureshi SA
    Spine J; 2015 Oct; 15(10):2254-70. PubMed ID: 26111597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining the scope of health technology assessment and types of health economic evaluation.
    Tanvejsilp P; Ngorsuraches S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S10-6. PubMed ID: 24964694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of the International Network of Agencies for Health Technology Assessment.
    Hailey D
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():24-7. PubMed ID: 19500434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview.
    Dasbach EJ; Elbasha EH
    Pharmacoeconomics; 2017 Jul; 35(7):673-683. PubMed ID: 28456972
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.